N-(Oxan-4-yl)(tert-butoxy)carbohydrazide

Catalog No. :
ACXLNP943
CAS No. :
959160-28-2
Molecular Formula :
C10H20N2O3
Molecular Weight :
216.28

IUPAC Name:tert-butyl 1-(tetrahydro-2H-pyran-4-yl)hydrazine-1-carboxylate

N-(Oxan-4-yl)(tert-butoxy)carbohydrazide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$323.00Login to see priceInquiryInquiry
100mg95%$473.00Login to see priceInquiryInquiry
250mg95%$669.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Oxan-4-yl)(tert-butoxy)carbohydrazide
IUPAC Nametert-butyl 1-(tetrahydro-2H-pyran-4-yl)hydrazine-1-carboxylate
MDL No.MFCD28634572
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESCC(OC(N(C1CCOCC1)N)=O)(C)C
InChI KeyWOUVQMPDKDWICZ-UHFFFAOYSA-N
SynonymHydrazinecarboxylic acid, 1-(tetrahydro-2H-pyran-4-yl)-, 1,1-dimethylethyl ester;tert-butyl 1-(tetrahydro-2H-pyran-4-yl)hydrazine-1-carboxylate
CAS No.959160-28-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXLNP943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFHYM527 route compound structure diagram
    ACFHYM5271187974-47-5 In Stock
  4. Then
  5. ACXLNP943 route product structure diagram
    ACXLNP943959160-28-2
Inquiry

2. ACXLNP943 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTMVN130 route compound structure diagram
    ACTMVN130693287-79-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXLNP943 route product structure diagram
    ACXLNP943959160-28-2
Inquiry

Comments (0)